What is it about?

The expression of Topoisomerase II alfa (TOP2A) may predict the efficacy of anthracyclines in patients with adrenocortical carcinomas, thus representing a new potential predictive marker for chemotherapy with EDP scheme.

Featured Image

Read the Original

This page is a summary of: Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer, Endocrine Related Cancer, April 2017, Bioscientifica,
DOI: 10.1530/erc-17-0095.
You can read the full text:

Read

Contributors

The following have contributed to this page